Cargando…

Interaction of Hb Adana (HBA2: c.179G>A) with Deletional and Nondeletional α (+)-Thalassemia Mutations: Diverse Hematological and Clinical Features

We describe 27 cases of mild-to-severe α-thalassemia (α-thal) syndrome caused by interaction of Hb Adana [α59(E8)Gly→Asp, GGC>GAC (α2)] with deletional and nondeletional α(+)-thal mutations in Indonesian patients. Hematological profiles and clinical manifestations of all patients were assessed by...

Descripción completa

Detalles Bibliográficos
Autores principales: Nainggolan, Ita M., Harahap, Alida, Ambarwati, Debby D., Liliani, Rosalina V., Megawati, Dewi, Swastika, Maria, Setianingsih, Iswari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667679/
https://www.ncbi.nlm.nih.gov/pubmed/23614625
http://dx.doi.org/10.3109/03630269.2013.775149
Descripción
Sumario:We describe 27 cases of mild-to-severe α-thalassemia (α-thal) syndrome caused by interaction of Hb Adana [α59(E8)Gly→Asp, GGC>GAC (α2)] with deletional and nondeletional α(+)-thal mutations in Indonesian patients. Hematological profiles and clinical manifestations of all patients were assessed by routine procedures. The genotypes were generated by a multiplex-polymerase chain reaction (m-PCR), PCR-RFLP (restriction fragment length polymorphism)-based method, and DNA sequencing. The α-thal patients who had Hb Adana in combination with the 3.7 kb deletion mostly have mild-to-moderate anemia. In contrast, patients who were compound heterozygotes for Hb Adana and nondeletional mutations, generally showed a more severe anemia and it mostly presented in childhood. Thus, accurate diagnosis of α-thal disorders is not only important for future management of these patients but also for providing proper genetic counseling to the family.